April 08, 2020 Biopharma venture investors shrug off Covid-19 First-quarter venture investments barely register the pandemic - huge cash reserves should protect funding for biotech start-ups this year.
January 16, 2019 Smaller groups await Bristol-Myers Squelgene fallout Celgene had many fingers in many pies – so what will happen now to its smaller collaborators?
